Vafeidou, K.; Psoma, O.; Dimakopoulos, G.; Apostolidis, E.; Sarvani, A.; Gavriilaki, E.; Doumas, M.; Tsimihodimos, V.; Kotsa, K.; Koufakis, T.
Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors. Pharmaceuticals 2025, 18, 807.
https://doi.org/10.3390/ph18060807
AMA Style
Vafeidou K, Psoma O, Dimakopoulos G, Apostolidis E, Sarvani A, Gavriilaki E, Doumas M, Tsimihodimos V, Kotsa K, Koufakis T.
Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors. Pharmaceuticals. 2025; 18(6):807.
https://doi.org/10.3390/ph18060807
Chicago/Turabian Style
Vafeidou, Kyriaki, Ourania Psoma, Georgios Dimakopoulos, Evangelos Apostolidis, Anastasia Sarvani, Eleni Gavriilaki, Michael Doumas, Vassilios Tsimihodimos, Kalliopi Kotsa, and Theocharis Koufakis.
2025. "Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors" Pharmaceuticals 18, no. 6: 807.
https://doi.org/10.3390/ph18060807
APA Style
Vafeidou, K., Psoma, O., Dimakopoulos, G., Apostolidis, E., Sarvani, A., Gavriilaki, E., Doumas, M., Tsimihodimos, V., Kotsa, K., & Koufakis, T.
(2025). Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors. Pharmaceuticals, 18(6), 807.
https://doi.org/10.3390/ph18060807
